Patent details

EP2471530 Title: REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2471530
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12162555.2
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
01/06/2006
Grant date:
11/01/2017
EP Publication Date:
04/07/2012
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
04/04/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/01/2017
EP B1 Publication Date:
11/01/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
31/05/2026
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
02/10/2020
 
 

 

Name:
PTC Therapeutics, Inc.
Address:
100 Corporate Court, Middlesex Business Center, SOUTH PLAINFIELD, NJ 07080, United States of America (US)

Historical Applicant/holder

From:
10/10/2017
To:
02/10/2020

 

Name:
BioElectron Technology Corporation
Address:
350 North Bernardo Avenue, 94043, MOUNTAIN VIEW, CA, United States of America (US)

From:
11/01/2017
To:
10/10/2017

 

Name:
Edison Pharmaceuticals, Inc.
Address:
350 North Bernardo Avenue, MOUNTAIN VIEW, CA 94043, United States of America (US)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
04/04/2017
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Miller, Guy M.,
Address:
Mountain View, CA California 94043, United States of America (US)

2

Name:
Hecht, Sidney M.,
Address:
Charlottesville, VA Virginia 22904-4319, United States of America (US)

Priority

1

Priority Patent Number:
776028 P
Priority Date:
22/02/2006
Priority Country:
United States of America (US)

2

Priority Patent Number:
701815 P
Priority Date:
21/07/2005
Priority Country:
United States of America (US)

3

Priority Patent Number:
686826 P
Priority Date:
01/06/2005
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/355; A61P 3/00; A61P 25/28;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
44/20
Publication date:
28/10/2020
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
46/17
Publication date:
15/11/2017
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
16/17
Publication date:
19/04/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
02/17
Publication date:
11/01/2017
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201702
Publication date:
11/01/2017
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202001927A
Date Registered:
02/10/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Marks & Clerk (Luxembourg) LLP
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
PTC Therapeutics, Inc.
Address:
100 Corporate Court, Middlesex Business Center, SOUTH PLAINFIELD, NJ 07080, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201702001A
Date Registered:
10/10/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Marks & Clerk (Luxembourg) LLP
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
BioElectron Technology Corporation
Address:
350 North Bernardo Avenue, 94043, MOUNTAIN VIEW, CA, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
20/05/2025
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
14/11/2017 Outgoing Correspondence Letter registration deed 1 PDF /3/1/5/3/2/0800123513/docs/ep12162555.2_1_173943l118.pdf
10/10/2017 Request for Change First filed deed 4 PDF /3/1/5/3/2/0800123513/docs/ep12162555.2_4_rfc20171024041635192.pdf
13/04/2017 Outgoing Correspondence Letter no formal defects 1 PDF /3/1/5/3/2/0800123513/docs/ep12162555.2_2_131072l271.pdf
04/04/2017 Claims First filed claims 11 PDF /3/1/5/3/2/0800123513/docs/ep12162555.2_0_claims20170404163938132.pdf
04/04/2017 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /3/1/5/3/2/0800123513/docs/ep12162555.2_3_incomingcorrespondenceelectronic20170404163940253.pdf